The current valuation score of Apellis Pharmaceuticals Inc is 7.55, ranking 64 out of 156 in the Pharmaceuticals industry. Its current P/E ratio is 38.75, which is 497.84% below the recent high of 231.69 and 155.95% above the recent low of -21.68.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.